Citation 132914

LIU,J:. (1995). PHARMACOLOGY OF OLEANOLIC ACID AND URSOLIC ACID.. 49(2)

Citation Details

Title	PHARMACOLOGY OF OLEANOLIC ACID AND URSOLIC ACID.
Authors	LIU,J:
Year	1995
Volume	49
Issue	2

Summary

Year: 1995

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIHEPATOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	ACTIVE
2	ELASTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEANOLIC ACID	ACTIVE
3	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEANOLIC ACID	ACTIVE
4	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEANOLIC ACID	ACTIVE
5	LIPOXYGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEANOLIC ACID	ACTIVE
6	CYCLOOXYGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEANOLIC ACID	ACTIVE
7	COMPLEMENT(GENERAL) ENZYME INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEANOLIC ACID	ACTIVE
8	ANTIMUTAGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEANOLIC ACID	ACTIVE
9	TUMOR PROMOTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEANOLIC ACID	ACTIVE
10	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEANOLIC ACID	ACTIVE
11	CARCINOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	ACTIVE
12	CELL DIFFERENTIATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEANOLIC ACID	ACTIVE
13	CELL DIFFERENTIATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEANOLIC ACID	ACTIVE
14	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEANOLIC ACID	ACTIVE
15	CARCINOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN HUMANS	OLEANOLIC ACID	ACTIVE
16	ANTIHYPERLIPEMIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	ACTIVE
17	ANTIHYPERLIPEMIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	ACTIVE
18	ANTIHYPERLIPEMIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	ACTIVE
19	ANTIULCER ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	ACTIVE
20	TOXIC EFFECT(GENERAL)	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	ACTIVE
21	TOXIC EFFECT(GENERAL)	PHARMACOLOGY OF COMPOUND - IN HUMANS	OLEANOLIC ACID	INACTIVE
22	ANTITOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	ACTIVE
23	ANTICARIES ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEANOLIC ACID	ACTIVE
24	ANTIFERTILITY EFFECT(UNSPECIFIED)	PHARMACOLOGY OF COMPOUND - IN VIVOANTIFERTILITY	OLEANOLIC ACID	ACTIVE
25	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	OLEANOLIC ACID	ACTIVE
26	ANTIYEAST ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	OLEANOLIC ACID	ACTIVE
27	HYPOGLYCEMIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	ACTIVE
28	ANTIHEPATOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN HUMANS	OLEANOLIC ACID	ACTIVE
29	ANTIINFLAMMATORY ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	ACTIVE
30	ANTIINFLAMMATORY ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	ACTIVE
31	ANTIINFLAMMATORY ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	ACTIVE
32	ANTIINFLAMMATORY ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	ACTIVE
33	ANTIINFLAMMATORY ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	ACTIVE
34	ANTIINFLAMMATORY ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	ACTIVE
35	ANTIINFLAMMATORY ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	OLEANOLIC ACID	ACTIVE
36	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	URSOLIC ACID	ACTIVE
37	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	URSOLIC ACID	ACTIVE
38	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	URSOLIC ACID	ACTIVE
39	ANTIINFLAMMATORY ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	URSOLIC ACID	ACTIVE
40	ANTIINFLAMMATORY ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	URSOLIC ACID	ACTIVE
41	ANTIINFLAMMATORY ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	URSOLIC ACID	ACTIVE
42	ANTIHYPERLIPEMIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	URSOLIC ACID	ACTIVE
43	ANTIHYPERLIPEMIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	URSOLIC ACID	ACTIVE
44	ANTIULCER ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	URSOLIC ACID	ACTIVE
45	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	URSOLIC ACID	ACTIVE
46	ANTIHYPERLIPEMIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	URSOLIC ACID	ACTIVE
47	CARCINOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	URSOLIC ACID	ACTIVE
48	CELL DIFFERENTIATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	URSOLIC ACID	ACTIVE
49	CELL DIFFERENTIATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	URSOLIC ACID	ACTIVE
50	ANTIMUTAGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	URSOLIC ACID	ACTIVE
51	TUMOR PROMOTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	URSOLIC ACID	ACTIVE
52	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	URSOLIC ACID	ACTIVE
53	LIPOXYGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	URSOLIC ACID	ACTIVE
54	CYCLOOXYGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	URSOLIC ACID	ACTIVE
55	COMPLEMENT(GENERAL) ENZYME INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	URSOLIC ACID	ACTIVE
56	ELASTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	URSOLIC ACID	ACTIVE
57	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	URSOLIC ACID	ACTIVE
58	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	URSOLIC ACID	ACTIVE
59	ANTIHEPATOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	URSOLIC ACID	ACTIVE

Citation 132914

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1